Key result
Laser photocoagulation significantly reduced serum Ang-2 and VEGF levels in patients with type 2 diabetes and proliferative diabetic retinopathy.
Why the study?
Does laser photocoagulation reduce serum Ang-2 and VEGF levels in T2DM patients with proliferative diabetic retinopathy?
Observational (n=160)
No
Does laser photocoagulation reduce serum Ang-2 and VEGF levels in T2DM patients with proliferative diabetic retinopathy?
Laser photocoagulation reduces serum Ang-2 and VEGF levels in T2DM patients with proliferative diabetic retinopathy, suggesting the Ang/Tie system plays a role in disease progression.
Should not yet alter retinopathy management; supports Ang/Tie involvement but remains hypothesis-generating pending randomized confirmation.
AIM: To determine the effects of laser photocoagulation on serum levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), soluble angiopoietin receptor Tie-2 (Tie-2), Ang-1/Ang-2 ratio and vascular endothelial growth factor (VEGF) in patients with type 2 diabetes mellitus (T2DM) and proliferative diabetic retinopathy (PDR). We also explored the role of the Ang/Tie system in PDR. METHODS: 160 patients with T2DM, including 50 patients with non-diabetic retinopathy (NDR), 58 patients with non-proliferative diabetic retinopathy (NPDR), and 52 patients with PDR were enrolled in this study. Serum Ang-1, Ang-2, Tie-2 receptor and VEGF levels were measured using enzyme-linked immunosorbent assays for all patients and were repeated in 26 patients who underwent laser photocoagulation two months after the procedure. RESULTS: The median levels of Ang-2 and VEGF in serum were significantly higher in the NPDR group (4.23 ng/mL and 303.2 pg/mL, respectively) compared to the NDR group (2.67 ng/mL and 159.8 pg/mL, respectively, P<0.01), with the highest level in the PDR group (6.26 ng/mL and 531.2 pg/mL, respectively, P<0.01). The median level of Ang-1 was significantly higher in the NPDR group (10.77 ng/mL) compared to the NDR group (9.31 ng/mL) and the PDR groups (9.54 ng/mL) (P<0.05), while no difference was observed between the PDR and NDR groups. Ang-1/Ang-2 ratio of PDR group was lowest in three groups (1.49 vs 2.69 and 2.90, both P<0.01). The median level of Tie-2 was not significantly different among three groups (P>0.05). Ang-2 was positively correlated with VEGF and Tie-2 in the PDR and NPDR groups (both P<0.05). Among the 26 patients who underwent laser photocoagulation, serum Ang-2 and VEGF levels significantly decreased (both P<0.05), whereas serum Ang-1 level and Ang-1/Ang-2 ratio were weakly increased (P>0.05). The median levels of Ang-2 and VEGF in serum were highest in PDR group, however, Ang-1/Ang-2 ratio of PDR group was lowest in three groups. CONCLUSION: Laser photocoagulation can reduce serum Ang-2 and VEGF levels. The Ang/Tie system and VEGF play an important role in the development and progression of T2DM patients with PDR.
No takes yet. Share an insight, caveat, or question.
You et al. (2014) conducted an observational in Type 2 diabetes mellitus with proliferative diabetic retinopathy (n=160). Laser photocoagulation vs. Pre-operative baseline was evaluated on Serum Ang-2 levels (ng/mL) (p=0.043). Laser photocoagulation significantly reduced serum Ang-2 and VEGF levels in patients with type 2 diabetes and proliferative diabetic retinopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: